These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 531036)

  • 1. The membrane abnormalities in paroxysmal nocturnal hemoglobinuria (PNH).
    Rosse WF; Adams JP
    Prog Clin Biol Res; 1979; 30():457-61. PubMed ID: 531036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Wiedmer T; Sims PJ; Rosse WF
    J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria.
    Schultz DR
    Am J Med; 1989 Sep; 87(3N):22N-29N. PubMed ID: 2484793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of gangliosides in erythrocytes of paroxysmal nocturnal hemoglobinuria.
    Nakakuma H; Kawaguchi T; Horikawa K; Hidaka M; Yonemura Y; Kawakita M; Kagimoto T; Iwamori M; Nagai Y; Takatsuki K
    J Clin Invest; 1990 May; 85(5):1456-61. PubMed ID: 2185273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.
    Jenkins DE; Hartmann RC; Kerns AL
    J Clin Invest; 1967 May; 46(5):753-61. PubMed ID: 6025481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-lymphocytes escape membrane defect in paroxysmal nocturnal haemoglobinuria.
    Cooper MR; Currie MS; Rustagi PK; Logue GL
    Br J Haematol; 1983 Oct; 55(2):263-71. PubMed ID: 6604541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the alternative pathway of complement by pH.
    Fishelson Z; Horstmann RD; Müller-Eberhard HJ
    J Immunol; 1987 May; 138(10):3392-5. PubMed ID: 2952717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM; Schönermark S; Roelcke D
    J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.
    Dixon RH; Rosse WF
    J Clin Invest; 1977 Feb; 59(2):360-8. PubMed ID: 833281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBC transfusions in paroxysmal nocturnal hemoglobinuria.
    Gockerman JP; Brouillard RP
    Arch Intern Med; 1977 Apr; 137(4):536-8. PubMed ID: 849085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Membrane structure abnormality and complement sensitivity of PNH erythrocytes].
    Matsumoto N; Hiroshige Y; Takahashi M
    Nihon Rinsho; 1979 Dec; 37(12):3900-8. PubMed ID: 395338
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.
    Holguin MH; Wilcox LA; Bernshaw NJ; Rosse WF; Parker CJ
    J Clin Invest; 1989 Nov; 84(5):1387-94. PubMed ID: 2478585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation.
    Nakakuma H; Hidaka M; Nagakura S; Nishimura Y; Iwamoto N; Horikawa K; Kawaguchi T; Kagimoto T; Takatsuki K
    J Clin Invest; 1995 Jul; 96(1):201-6. PubMed ID: 7542278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T
    Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment.
    Risitano AM; Notaro R; Pascariello C; Sica M; del Vecchio L; Horvath CJ; Fridkis-Hareli M; Selleri C; Lindorfer MA; Taylor RP; Luzzatto L; Holers VM
    Blood; 2012 Jun; 119(26):6307-16. PubMed ID: 22577173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH).
    Nakakuma H
    Am J Hematol; 1996 Sep; 53(1):22-9. PubMed ID: 8813092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.